Try our Advanced Search for more refined results
Health - November, 2009
207 articles
- Calif. Court Cuts McKesson Penalty From $15M To $2M
- Abbott Settles TriCor Patent Spat With Teva
- High Court Mulls Statute Of Limitations In Investor Suits
- Invisalign Wins Right To Amend In Battle With Counsel
- Depomed Fingers Lupin In Diabetes Drug Patent Case
- NJ Law To Govern Punitives In Zometa, Aredia Cases
- Navy, Hospital Workers Settle Nighttime Pay Claims
- Contract Claims V. Mayo Nixed In Alzheimer's IP Spat
- Punitive Damages Fight Revived In ObTape Case
- Henry Schein To Create Distribution Co. In $55M Merger
- High Court Refuses Cordis, Boston Scientific Appeals
- Wyeth V. Levine Won't Affect Liability Win For Perrigo
- Generic-Drug Labels Must Provide Warnings: 8th Circ.
- Stryker To Buy Medical Device Reprocessor For $525M
- Wrongful Death Suit Over J&J's Remicade Closed
- Daiichi Sankyo Goes After Sandoz For Evoxac ANDA
- Consolidated Defendants Tossed From Colchicine Spat
- Court Rules For Wright In Knee Implant Patent Suit
- QLT Settles Visudyne Royalty Spat For $20M
- The Complications Of Successorship Decisions
- GSK Prevails In Sales Rep Overtime Suit
- Wal-Mart, CVS Win Bid To Toss Drug Overcharge Suit
- Ex-Taro Exec, Son Hit With Penalties In SEC Case
- Court Affirms St. Jude Win In Noncompete Dispute
- GSK Pulls H1N1 Vaccine Amid Reports Of Reactions
- McKesson Can Pursue Suit V. Iran Over Dairy Plant
- Review: Four Corners Nephrology V. Mercy Medical
- Jury Tacks On $28M In Punitive Damages For Pfizer
- J&J Wants Consumer Class Tossed From AWP Suit
- Thermo-Ply Wins Prosthetics Suit On Obviousness
- Hospital Operator Takes UPMC Antitrust Suit To 3rd Circ.
- FDA Launches Safety Review Of Weight Loss Drug
- Merck Wins Bid To Toss Texas Medicaid Fraud Suit
- 2nd Bellwether Case Over Merck's Fosamax Nixed
- Zicam Maker Urges FDA To Reverse Anosmia Finding
- Ascension Dukes It Out Over Nurse MDL Coverage
- Institutional Investors As Class Representatives
- Medical Ed. Co. Says Ex-Worker Stole Source Codes
- $125M Deal Awaits OK In Bristol-Myers Class Action
- Aetna Seeks Dismissal Of Ob/Gyn Coverage Suit
- 1st Circ. Crushes Objection To $24M Zoladex Deal
- Pfizer Hit With $6.3M Prempro Verdict In Pa.
- Medical Transcription Co. ETransplus Faces OT Action
- Rehabilitation Act Covers Contractor Claims: 9th Circ.
- State Claims Reinstated In Buffalo Hospital Suits
- MvuInvestors Appeal Loss To GE In Patent Deal Suit
- P&G Recalls Nasal Spray Over Bacteria Risk
- Teva Will Appeal Loss In Vigamox Eyecare Patent Suit
- Exela Takes Alphagan Patent Ruling To Fed. Circ.
- FDA Enforcement Heating Up
- McCall Guilty Of McKesson-HBOC Fraud, Lapine Free
- Fed. Circ. Says Ads Invalidated Supplement Patent
- St. Jude Wins Motion To Recover Stolen Trade Secrets
- Novartis Wins Herpes Drug Patent Fight Against Teva
- Saturday Health Care Vote Looms In Senate
- Athena Hits Ambry With 4 Genetic Testing Patent Suits
- Apex Fights $13M Award To I-Flow Over Pump Patent
- EU To Request Drug Patent Deal Details
- ARS Investor Seeks To Dump FINRA As Arbitrator
- OraSure To Pay $3M To Settle HIV Test Patent Suit
- Sughrue Mion Grabs Calif. Biotech Patent Attorney
- 9th Circ. Allows CTI Contract Dispute To Go Forward
- Congress Demands Health Insurers Explain Rate Hikes
- Plavix Label Revised To Include Prilosec Warning
- Bayer, GE, Covidien MRI Agents Carry Higher Risk: FDA
- House Dems Ask GAO To Look At Drug Prices
- FDA Warns Medtronic Over Heart Rhythm Unit
- Skin Clinic Chain Trims ERISA Claims From OT Suit
- Edwards Drags Medtronic To Court Over Valve Patent
- PRE Loses Injunction Bid In Device Patent Suit
- Norbrook, Boehringer End Dog Drug IP Brawl
- Teva Drops 2 Copaxone Claims Against Sandoz
- DeCode Files For Ch. 11 With Plan To Sell Assets
- CSI Recalls Sheath Introducers Amid Breakage Fears
- Seroquel Plaintiffs Rebuked Over Video Testimony Bid
- Streck Appeals Conflicting Patent Board Finding
- Importer Seeks Lower Duty On Vitamin Pills
- Takeda Appeals Win For Teva In Generic Prevacid Case
- Smith & Nephew Not Enjoined In Wound Therapy IP Suit
- Seller Of Fake Cancer Drugs Loses Bid For New Trial
- FDA Warns Abbott To Fix 'Adulterated' Devices
- McDermott Adds Darby & Darby Attys To NY IP Team
- Eli Lilly Escapes Suit Over Prozac Slaying, Suicide
- State AGs Back Health Insurance Antitrust Exemption
- Dermatological Patent Spat Ends In Settlement
- 11th Circ. Rejects HealthSouth Exec Sentence Again
- Acacia Unit, GE Reach Accord In Medical Imaging Suit
- Suit Says Health Insurance Distributor Stiffed Brokers
- AstraZeneca Fights Bid To Videotape Seroquel Expert
- Class Certified In Abbott Contact Lens Solution Suit
- Wyeth, Schwarz Off Hook In Generic Reglan Suit
- FTC's Carilion Clinic Breakup — Outlier Or Omen?
- Prosthetic Liner Maker Accuses Rival Of Monopoly
- Bristol-Myers To Divest Mead Johnson Stake
- Class Cert. Bid Nixed In J&J Panacryl Sutures MDL
- State Farm Facing Class Action Over Lowball Payouts
- J&J Appeals Loss In CIBA Contact Lens Patent Suit
- W.Va. Plaintiffs To Fight Baycol MDL Ruling In 8th Circ.
- 9th Circ. Revives Amgen Drug Rebates Dispute
- More Bodybuilding Products Recalled Over Steroids
- Fed Circ. Refuses To Nix Injunction On USPTO Rules
- Dey, Others Fork Over $4.3M To End Iowa AWP Suit
- 8th Circ. Upholds Tossing Of Baycol Expert Testimony
- Frommer Bumped From Merck, ProThera Patent Suit
- Cephalon, Barr Settle Fentora Patent Battles
- FDA Warns Public About Post-Surgery Infusions
- Insurer Wants Out Of Class Action Over Medical Bills
- Generics Maker Says Drug-Safety Program Gets Abused
- Arthrex Hit With Patent, Trade Secrets Claims
- FDA Issues Safety Warning About 5 Genzyme Drugs
- Prosthetic Device Maker Hits Rival With Patent Suit
- WL Gore, Synovis End Feud Over Staple Seal Patent
- Wage-And-Hour Issues In The Life Sciences Industry
- Lifeline Appeals Dismissal Of Suit Against Insurers
- Hospital Read Too Much Into 3rd Circ. ADA Ruling: Judge
- 7th Circ. To Review Medicare Contract Antitrust Spat
- Abbott Gains Pain-Relief Drug In $190M Deal
- Growing Safe Food Act Vows Aid To Small Farms
- Ex-Tyco Director Walsh Settles NJ Suit For $5.6M
- Quest Unveils $750M Notes Offering To Buy Back Debt
- Endo To Pay $23M To Settle Patent Suit Over Patch
- Class Action Alleges Plot To Price-Fix Plasma Therapies
- St. Jude Parries Insurer's Bid To Sidestep Coverage
- Sanctions Bid Nixed In 2nd Pittsburgh Hospital Suit
- Ga. High Court Narrows Noncompete Injunction
- ARS Investor Fights To Keep Citigroup In Court
- Lilly To Pay Utah $24M Over Zyprexa Marketing
- CB Fleet Settles With Axis On Bowel Cleanser Suits
- Senate Mulls Mandatory Sick Leave Amid Swine Flu
- Teva Launches Generic Prevacid After Patent Win
- Different FDA Regs For Devices, Drugs Rule Preemption
- Knobbe Martens Nabs Ex-Ranbaxy VP Of Global IP
- Biovail Accuses Elan, Fournier Of Misleading USPTO
- Merck Answers USPTO In Singulair Patent Re-Exam
- Conceptus Fails To Block Rival Contraceptive System
- Fraud Claims Cut From Actimmune Marketing MDL
- Cancer Widow Denied Cert. In Life Investors Suit
- Threshold Settles Shareholder Action For $10M
- Bilski Argument Puts Spotlight On Business Methods
- Hospital Wage-And-Hours The Next Wave, Lawyers Say
- Children's Hospital Wins Initial Victory In Antitrust Spat
- Celexa, Lexapro Deal Covers Civil Claims Only
- Sonova Snaps Up Advanced Bionics For $489M
- PacifiCare Loses Challenge Of Potential $1.3B Fine
- Takeda Sues Teva Over Sleeping Pill ANDA
- Plaintiffs' Demand For Docs Too Late In Seroquel MDL
- Your Medical History Up For Grabs
- Ark. High Court Tosses Nexium Marketing Fraud Suit
- Allergan Hits Alcon With Combigan Patents
- House Passes Health Care Bill
- Ill. Cancer Hospital Hit With Whistleblower Suit
- Jury Awards I-Flow $13M In Medical Pump Patent Spat
- Antitrust Concerns Revived As CVS Reveals FTC Probe
- Plaintiffs Drop Lipitor Class Action Against Pfizer
- Boston Scientific To Pay $296M To Settle Probe
- DOJ Probes Abbott's Sales, Marketing Of Depakote
- Mirapex Buyers Bid For Class Status In Antitrust Case
- House Clears Bill To Boost Medical Isotope Supply
- Infosint Seeks $43M Damages In Citalopram Suit
- $1.7B Centocor Patent Award Against Abbott Stands
- Troutman Atty Tagged In $50M Omnicare Scheme
- P&G Sued Over Vicks With Vitamin C Products
- Insurers Shouldn't Fear New FTC Powers, Attys Say
- TPG Capital, Pension Plan To Buy IMS Health For $5B
- McKesson Wins Bid For Discovery Docs In AWP Fight
- Investors Slap Hansen Medical With Securities Action
- Centurion Recalls Kits With Faulty Tracheal Tubes
- Repealing Insurers' Antitrust Immunity?
- Sanctions Denied In Pittsburgh Hospital Pay Policy Suit
- Shire Settles With Apotex Over Epilepsy Patents
- Senate Challenges Health Insurer Spending Reports
- After Jury Win, Patent Board Turns Tables On Streck
- RehabCare To Acquire Triumph Healthcare For $570M
- Mutual Pharma Sanctioned In Sulindac Suit
- AtriCure To Pay $4M Over Ablation Device Marketing
- Pfizer Prempro Verdict Rumored To Be $75M
- American Regent Expands Pain Injection Vial Recall
- Novartis Strikes $125M Deal For Chinese Vaccine Co.
- Online Vendor Recalls Supplements Over Steroids
- House Dems Amend Health Bill As Vote Approaches
- Differential Diagnosis — Trending Toward Exclusion
- Illumina Hits Affymetrix Over New Gene Tech Patent
- Kaiser Appeals Abbott MDL Antitrust Patent Case
- Belgian Suit Nixed In Medical Supply Contract Dispute
- Judge Pares Down Indirect Buyers' Wellbutrin Action
- Supreme Court Braces For Bilski Battle
- Omnicare, Teva Unit End Kickback Claims For $112M
- Sanofi, Bristol-Myers Try To Quash Apotex Subpoenas
- Breast Cancer Gene Patent Case Survives Bids To Toss
- Allergan Lashes Out At Eye Center In Patent Dispute
- Roche Drops NJ Boniva Suits After Teva Pulls ANDA
- SEC Drops Insider Trading Case Over J&J Deal
- FTC Extends Scrutiny Of MDS' $650M Sale To Danaher
- Neuralstem Loses Bid To Toss Stem Cell Patent Case
- Streck Wins Patent Suit Over Hematology Technology
- FDA Issues Warning Over Eli Lilly Diabetes Drug Byetta
- High Court Asks Solicitor General For Brief In Pfizer Suit
- $27.5M Settles Universal Health Kickback Suit
- 8th Circ. OKs $27M Damages Dismissal In Prempro Case
- Lilly To Appeal Invalidity Ruling For Sun In Gemzar Suit
- Supreme Court Declines Apotex Appeal Of Plavix Suit
- Conn. AG To Look Into Flu Vaccine Price-Gouging
- PerkinElmer Had Duty To Promote Printing Unit: 1st Circ.
- Blue Cross Montana Seeks To Merge Car Crash Suits
- High Court Rebuffs Rx.com's Group Boycott Suit
- Purdue Hits Cipher With Patent Suit Over Ultram
- Solvay Wants Androgel Indirect Purchaser Cases Axed